Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2023-11-22 00:00:00 ET · period of report 2023-11-21 · accession 0000892251-23-000187 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-22 | 2023-11-21 | MEDP | Medpace Investors, LLC | 10% | S - Sale | $277.37 | -25.0K | 5.71M | -0.4% | -$6.93M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-21 | S | D | 25,000 | $277.37 | 5,714,947 | D | — | — | (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $275.67 to $279.49. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |